Cerus reported $34.78M in Operating Expenses for its fiscal quarter ending in December of 2024.





Operating Expenses Change Date
Cerus USD 34.78M 2.98M Dec/2024
GRIFOLS EUR 1.65B 101M Sep/2026
Haemonetics USD 145.79M 448K Sep/2026
Neogen USD 224.6M 2.4M Jun/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Quidel USD 606.8M 39.4M Sep/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 77.95M 5.48M Sep/2026
Terumo JPY 331.37B 109.04B Sep/2026
Utah Medical Products USD 6.16M 447K Mar/2026